Careers  |  Sign In  |  Register

Emerging Strategies to Reduce the Burden of Food Allergy in Children

Course List

  • CME Information

Provider Statement

These continuing medical education activities are provided by Vindico Medical Education.

Support Statement

These activities are supported by an educational grant from DBV Technologies.


Food allergy is a major public health concern that affects approximately 8% of children in the United States, posing a significant burden on quality of life and risk of serious adverse reactions. Currently, a lack of awareness exists around this allergic disorder and its pathophysiology. Thus, proper diagnosis and management is critical to reduce the risk of severe allergic reactions as well as adverse outcomes. In these CME activities, expert faculty will discuss the diagnosis and management of patients with food allergy and how practitioners can effectively conduct a clinical evaluation and diagnosis of such allergy. The comparative benefits and limitations of emerging oral, subcutaneous, and sublingual immunotherapy will also be reviewed. Participants will gain a better understanding of the practical implications of immunotherapy for increasing the allergen response threshold.

Target Audience

The intended audience for these activities are allergists, pediatricians, and other health care professionals involved in the treatment of patients with food allergy.

Learning Objectives

Upon successful completion of these activities, participants should be better able to:

  • Assess the burden of food allergy in children.
  • Evaluate appropriate tools and strategies for the diagnosis and management of children with IgE-mediated food allergy.
  • Examine the comparative benefits and limitations of available and emerging methods for immunotherapy for the treatment of food allergy in children.
  • Explain the clinical and practical significance of increasing the allergen response threshold via immunotherapy.


Joseph L. Baumert, PhD
Associate Professor
Co-Director, Food Allergy Research & Resource Program
University of Nebraska
Lincoln, NE

Stanley M. Fineman, MD
Atlanta Allergy and Asthma
Marietta, GA

David Fleischer, MD
Associate Professor, Pediatrics-Allergy
Associate Section Head Director, Allergy and Immunology Center
Children's Hospital Colorado, University of Colorado Hospital
Aurora, CO

Matthew Greenhawt, MD
Director, Food Challenge and Research Unit
Children’s Hospital of Colorado
Aurora, CO

Ruchi S. Gupta, MD, MPH
Associate Professor of Pediatrics and Medicine
Northwestern Medicine, Feinberg School of Medicine
Director, Science and Outcomes of Allergy and Asthma Research Team
Clinical Attending Ann and Robert H. Lurie Children's Hospital Chicago
Chicago, IL

Wayne Shreffler, MD, MPH
Chief, Pediatric Allergy and Immunology
Associate Professor
Harvard Medical School
Massachusetts General Hospital
Boston, MA


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™, 0.25 credits per activity. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 30, 2018 to March 30, 2019.

How to Participate in this Activity and Obtain CME Credit

To participate in these CME activities, you must read the objectives, answer the pretest questions, view the content, complete the CME posttests, and complete the evaluations. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly for each activity. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

Faculty Members report the following relationship(s):

Joseph L. Baumert, PhD
Consulting Fee: DBV Technologies

Stanley M. Fineman, MD
Consulting Fee: Aimmune Therapeutics , DBV Technologies
Speakers Bureau: AstraZeneca, Boehringer Ingelheim, Genentech/Novartis, Shire
Contracted Research: Aimmune Therapeutics, DBV Technologies, Shire

David Fleischer, MD
Consulting Fee: Aimmune Therapeutics, DBV Technologies, INSYS, Intrommune, Kaleo Pharma
Contracted Research: Aimmune Therapuetics, DBV Technologies

Matthew Greenhawt, MD
Consulting Fee: Aimmune Therapeutics, DBV Technologies, Intrommune, Thermo Fisher
Speakers Bureau: ACAAI, Aimmune Therapeutics, DBV Technologies, Thermo Fisher
Received Non-CME Services Fee: Aimmune Therapeutics, DBV Technologies
Contracted Research: Agency for Healthcare Research and Quality KO8 Award, DBV Technologies
Advisory Board: Aimmune, DBV Technologies, Kaleo, Monsanto, Nutricia
Associate Editor: Annals of Allergy, Asthma, and Immunology
Co-Chair: Nestle international consensus panel on the use of hydrolyzed formula; AAAAI Primary Prevention of Food Allergy Working Group and Oral Immunotherapy Office-based Practice Working Group
Editorial Board: Allergy and Rhinology; Medscape Pediatrics; Infectious Diseases in Children
Member: AAAAI EGID, Anaphylaxix, Adverse Reaction to Food committees; CSACI Food Allergy in Schools Guideline Panel; ACAAI Annual Meeting Planning Committee, Chair, GI/Food Allergy Track chair; Chair, Food Allergy Committee; Medical Advisory team for the Allergy and Asthma Foundation of America and the International Association for Food Protein Entercolitis (non-financial); EAACI Task Force on Nutrition and Immunomodulation; NIAID Expert Panel on early introduction of peanut to prevent peanut allergy; Scientific Advisory Council, National Peanut Board

Ruchi S. Gupta, MD, MPH
Consulting Fee: Aimmune Therapeutics, BEFORE Brands, DBV Technologies, Kaleo Pharma
Contracted Research: Mylan Specialty, Thermo Fisher Scientific, United Health Group

Wayne Shreffler, MD, MPH
Scientific Advisory Board: Aimmune, Edisia Nutrition, Food Allergy Research & Education (FARE), Fress Therapeutics, Sanofi Pasteur

Reviewer reports the following relationship(s):

Ronald A. Codario, MD, EMBA FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Educational Tools

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at